Free tool
The FDA-approved BMI threshold for GLP-1 weight-loss medications is 30 or higher — or 27 or higher with a weight-related comorbidity such as type 2 diabetes, hypertension, sleep apnea, or dyslipidemia. Enter your height and weight below to calculate your BMI and see whether you meet the Wegovy or Zepbound prescribing criteria.
Your BMI
27.4
Overweight (eligible if comorbidities) · 27 — 29.9Wegovy and Zepbound are FDA-approved at BMI ≥27 with at least one weight-related comorbid condition. Without comorbidities, you would need BMI ≥30.
BMI is a screening tool, not a diagnosis. It does not account for muscle mass, bone density, or body composition. Talk to a licensed clinician about whether GLP-1 medications are appropriate for you.
The FDA approves Wegovy (semaglutide) and Zepbound (tirzepatide) for chronic weight management in adults with:
Insurance coverage for these medications often requires documentation of a failed lifestyle-intervention attempt and may apply stricter BMI thresholds than the FDA label.